We know what it takes to bring physical touch to cancer diagnostics.
Cellens is also supported by an exceptional team of scientific and industry advisors
Cellens, Inc. was founded as a Tufts University spinout based on research from Dr. Igor Sokolov’s laboratory. Dr. Sokolov had demonstrated the feasibility of using atomic force microscopy and machine learning for detection of cervical cancer, colon cancer and bladder cancer. Ms. Jean Pham co-founded Cellens Inc. with Dr. Sokolov to translate this cutting-edge technology into a clinically meaningful diagnostic platform.
In 2022, Cellens Inc. entered into an exclusive license agreement with Tufts University and simultaneously received a Notice of Allowance from the USPTO for one of its foundational patents. That same year, Dr. Amir Monemian and Dr. Nadia Makarova joined the core team as full-time Lead Scientist and Biophysics Engineer, respectively.
Cellens Inc. is now located in Cambridge, Massachusetts, the global life science innovation hub.